Solexa, Inc., later acquired by Illumina, released its platform, which combines sequencing-by-synthesis chemistry and cluster technology, in June 2006 (see 'Creating the Genome Analyzer').

When people think of DNA, they usually think of genes, the parts that code for proteins and drive inherited traits. But there ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.